go 6976 has been researched along with Chediak-Higashi Syndrome in 1 studies
Chediak-Higashi Syndrome: A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanabe, F | 1 |
| Kasai, H | 1 |
| He, L | 1 |
| Kin, T | 1 |
| Fujikado, T | 1 |
| Kumamoto, T | 1 |
| Hara, T | 1 |
| Iwata, T | 1 |
| Ito, M | 1 |
1 other study available for go 6976 and Chediak-Higashi Syndrome
| Article | Year |
|---|---|
Improvement of deficient natural killer activity and delayed bactericidal activity by a thiol proteinase inhibitor, E-64-d, in leukocytes from Chediak-Higashi syndrome patients in vitro.
Topics: Benzophenanthridines; Carbazoles; Cell Line, Tumor; Chediak-Higashi Syndrome; Cysteine Proteinase In | 2009 |